AcouSort AB (SE:ACOU)

:ACOU

ACOU

AcouSort AB

RESEARCH TOOLSreports

AcouSort AB (ACOU) Price & Analysis

0 Followers

ACOU Stock Chart & Stats

kr2.64

-kr3.18(-45.56%)

At close: Mar 06 4:00 PM EST

kr2.64

-kr3.18(-45.56%)

Day’s Range― - ―

52-Week Rangekr2.03 - kr4.48

Previous CloseN/A

Volume449.84K

Average Volume (3M)29.24K

Market Cap

kr64.55M

Enterprise Valuekr58.26M

Total Cash (Recent Filing)kr6.29M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)―

Beta0.45

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.12

Shares Outstanding21,163,902

10 Day Avg. Volume27,764

30 Day Avg. Volume29,240

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)3.27

Price to Sales (P/S)7.79

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.4

Revenue Forecast (FY)kr18.80M

Bulls Say, Bears Say

Bulls Say

No Reported DebtZero reported debt materially reduces refinancing and interest-rate risk and preserves financial flexibility. For a R&D-heavy medtech smallcap this improves runway against cash burn, supports continued investment in product development, and eases near-term solvency pressures.

Differentiated Acoustofluidic PlatformProprietary acoustofluidic technology (AcouWash) addresses a structural need in cell therapy and bioprocessing for label-free, continuous-flow washing and separation. This technical differentiation creates durable product-market fit opportunities and potential long-term adoption in regulated workflows.

Improving Revenue TrendA 22% revenue recovery in 2025 signals strengthening end-market demand and early commercial traction. Sustained top-line growth supports scale economics potential, helping narrow losses over time if the company can convert demand into higher volumes and improved gross margins.

Bears Say

Sustained LossesConsistent net losses and negative operating profits across multiple years indicate the core business is not yet profitable. Persistent negative earnings erode reserves, force ongoing external financing, and limit reinvestment capacity, raising long-term dilution and viability risks if trends persist.

Negative Operating Cash FlowRepeated negative operating cash flow shows the business does not self-fund operations and is reliant on financing. That structural cash burn increases execution risk, constrains ability to scale manufacturing or commercialization, and raises probability of future capital raises.

Reliance On Equity Funding And Small ScaleFluctuating equity levels imply recurring equity raises to cover losses; combined with a very small team (17 employees) this signals limited internal capacity and recurring dilution risk. Reliance on external funding and limited scale can slow commercialization and technology roll-out.

ACOU FAQ

What was AcouSort AB’s price range in the past 12 months?

AcouSort AB lowest stock price was kr2.03 and its highest was kr4.48 in the past 12 months.

What is AcouSort AB’s market cap?

AcouSort AB’s market cap is kr64.55M.

When is AcouSort AB’s upcoming earnings report date?

AcouSort AB’s upcoming earnings report date is May 27, 2026 which is in 51 days.

How were AcouSort AB’s earnings last quarter?

AcouSort AB released its earnings results on Feb 25, 2026. The company reported -kr0.12 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.12.

Is AcouSort AB overvalued?

According to Wall Street analysts AcouSort AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AcouSort AB pay dividends?

AcouSort AB does not currently pay dividends.

What is AcouSort AB’s EPS estimate?

AcouSort AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AcouSort AB have?

AcouSort AB has 21,163,902 shares outstanding.

What happened to AcouSort AB’s price movement after its last earnings report?

AcouSort AB reported an EPS of -kr0.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.775%.

Which hedge fund is a major shareholder of AcouSort AB?

Currently, no hedge funds are holding shares in SE:ACOU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AcouSort AB

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.